In order to find and gather data for this technical, financial, and market-oriented analysis of the Patient Engagement Solutions market, this market research study made considerable use of secondary sources, directories, and databases. To gather and validate crucial qualitative and quantitative data and evaluate market prospects, in-depth interviews were performed with a range of primary respondents, including important industry players, subject-matter experts (SMEs), C-level executives of significant market players, and industry consultants, among other experts. To get the final market size, the size of the market was evaluated using a variety of secondary research techniques and triangulated with inputs from primary research.
The research study's secondary sources include publications from government agencies like the WHO, ATA, AHA, and AAHM. Press releases; trade, business, and professional associations; business publications and research journals; corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); and other sources are examples of secondary sources. The total size of the global market was estimated by the collection and analysis of secondary data, and this estimate was confirmed by primary research.
Patient Engagement Solutions Market based on Component:
• Hardware
• Software
• Standalone Software
• Integrated Software
• Services
Patient Engagement Solutions Market based on Delivery Mode:
• PREMISE Mode
• CLOUD-BASED Mode
Patient Engagement Solutions Market based on Application:
• Health management
• Home health management
• Social
• Financial health management
Patient Engagement Solutions Market based on Therapeutic Area:
• Chronic diseases
• Cardiovascular diseases (CVD)
• Diabetes
• Obesity
• Other chronic diseases
• Women's health
• Fitness
• Other Therapeutic Areas
Patient Engagement Solutions Market based on Functionality:
• Introduction
• E-Prescribing
• Virtual Consultation
• Patient/Client Scheduling
• Document Management
Patient Engagement Solutions Market based on End User:
• Providers
• Payers
• Patients
• Other End users
Patient Engagement Solutions Market based on Geography:
• North America
o US
o Canada
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe (RoE)
• Asia Pacific (APAC)
o China
o Japan
o India
o Australia
o South Korea
o Rest of Asia Pacific (RoAPAC)
• Latin America (LATAM)
o Brazil
o Argentina
o Rest of South America
• Middle East and Africa (MEA)
o UAE
o Turkey
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
2022 saw a dominance of the web and cloud-based segments of the market. During the projected period, the segment is also expected to grow at the fastest rate.These solutions' growing popularity can be attributed to their integrated features, ease of use, minimal handling costs, ease of data backup, and remote access to real-time data tracking. Businesses are investing in web- and cloud-based patient engagement solutions for the reasons outlined above.
For example, Microsoft announced Microsoft Cloud for Healthcare in May 2020, the company's first industry-specific cloud. With capabilities like telemedicine and data analytics, the platform is meant to help doctors improve patient involvement and association across health teams. Patient data security, convenience of retrieval, and accessibility are offered by on-premise services. The preference for on-premise services stems mostly from having full access to the data on the premises.
The segment with the biggest share in 2022 was software and hardware, and during the course of the projection period, it is anticipated to grow at the quickest CAGR of roughly 17%. The solution's primary components are hardware and software for patient engagement. Due to its user-friendly interfaces and ongoing product updates, it is easy to install, utilise, and retrieve records. Popular mobile-first, customised, enterprise patient engagement tool from Allscripts is called FollowMyHealth. Providers, hospitals, and health systems use it to improve patient happiness and promote treatment quality.
Since communication is the foundation of any patient engagement solution, it has the highest revenue share (more than 35.0%) in 2022. The significant portion is ascribed to the upsurge in the requirement and acceptance of mhealth, telehealth, and additional virtual communication options through text, video, and voice. The epidemic has accelerated the already rapid uptake of virtual communication systems and increased their applicability to mental health, remote patient monitoring, and numerous other modalities.
With a revenue share of more than 40.0% in 2022, chronic disease management led the market. The high share of the segment is a result of several factors, including the ageing population in important markets, the frequency of chronic illnesses, and the COVID-19 pandemic-induced adoption of digital technologies. Patient engagement solutions assist in the management of chronic diseases by making it easier to avoid and identify the condition, as well as to manage it with a healthcare provider or on one's own.
In 2022, the outpatient health management sector accounted for about 35.0% of market revenue, making it the dominant segment. Over the course of the forecast period, the R&D and preventive care application sector, which comprises the others application segment, is expected to grow at the quickest pace of 17.0%. Individuals with chronic illness diagnoses require ongoing care and education about how to manage their condition. Patients are becoming more actively involved in the planning, monitoring, and optimisation of their care as a result of the growing healthcare consumerism.
In 2022, providers had the highest revenue shareomore than 45.0%. In addition to treating the greatest number of patients, providers are the first choice for consultation on anything from general to specialised medical issues. Therefore, the biggest users of patient engagement systems are these end users. Northwell Health in the United States implemented a Playback Health patient engagement platform in December 2021 at a few of its clinical facilities to encourage mobility and exchange point-of-care medical data while upholding HIPAA security regulations.
Some of the key players operating in patient engagement solutions market are IBM (US), McKesson Corporation (US), Allscripts (US), Cerner Corporation (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Symphony Care (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), WellStack(US), IQVIA (US), Vivify Health (US), Medhost (US), Validic (US) MEDISYSINC (US), and Patient point LLC (US).
• This report illustrates the most vital attributes of the Patient Engagement Solutions Market, which are driving and providing opportunities.
• This research gives an in-depth analysis of the Patient Engagement Solutions Market growth on the basis of several segments in the market.
• This report presents the predictions of the past and present trends of the Patient Engagement Solutions Market.
• This study also presents the competitive analysis, such as key strategies and capabilities of major players of the Patient Engagement Solutions Market.
Table of Contents 1. Executive Summary 2. Industry Outlook 2.1. Industry Overview 2.2. Industry Trends 3. Market Snapshot 3.1. Market Definition 3.2. Market Outlook 3.2.1. Porter Five Forces 3.3. Related Markets 4. Market characteristics 4.1. Market Overview 4.2. Market Segmentation 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. DRO - Impact Analysis 5. Component: Market Size & Analysis 5.1. Overview 5.2. Hardware 5.3. Software 5.4. Standalone Software 5.5. Integrated Software 5.6. Services 6. Delivery mode: Market Size & Analysis 6.1. Overview 6.2. PREMISE Mode 6.3. CLOUD-BASED Mode 7. Application: Market Size & Analysis 7.1. Overview 7.2. Health management 7.3. Home health management 7.4. Social 7.5. Financial health management 8. Therapeutic Area: Market Size & Analysis 8.1. Overview 8.2. Chronic diseases 8.3. Cardiovascular diseases (CVD) 8.4. Diabetes 8.5. Obesity 8.6. Other chronic diseases 8.7. Women's health 8.8. Fitness 8.9. Other Therapeutic Areas 9. Functionality: Market Size & Analysis 9.1. Overview 9.2. Chronic diseases 9.3. Cardiovascular diseases (CVD) 9.4. Diabetes 9.5. Obesity 9.6. Other chronic diseases 9.7. Women's health 9.8. Fitness 9.9. Other Therapeutic Areas 10. End User: Market Size & Analysis 10.1. Overview 10.2. Chronic diseases 10.3. Cardiovascular diseases (CVD) 10.4. Diabetes 10.5. Obesity 10.6. Other chronic diseases 10.7. Women's health 10.8. Fitness 10.9. Other Therapeutic Areas 11. Geography: Market Size & Analysis 11.1. Overview 11.2. North America (U.S., Mexico, Canada) 11.3. Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia, Rest of Europe) 11.4. Asia Pacific (Japan, China, India, Australia, South East Asia, Rest of APAC) 11.5. Latin America (Brazil, Argentina) 11.6. Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of Middle East and Africa) 12. Competitive Landscape 12.1. Competitor Comparison Analysis 12.2. Market Developments 12.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships 12.2.2. Product Launches and execution 13. Vendor Profiles 13.1. Allscripts Healthcare, LLC 13.1.1. Overview 13.1.2. Financial Overview 13.1.3. Product Offerings 13.1.4. Developments 13.1.5. Business Strategy 13.2. Orion Health 13.2.1. Overview 13.2.2. Financial Overview 13.2.3. Product Offerings 13.2.4. Developments 13.2.5. Business Strategy 13.3. Cerner Corporation 13.3.1. Overview 13.3.2. Financial Overview 13.3.3. Product Offerings 13.3.4. Developments 13.3.5. Business Strategy 13.4. Athenahealth, Inc. 13.4.1. Overview 13.4.2. Financial Overview 13.4.3. Product Offerings 13.4.4. Developments 13.4.5. Business Strategy 13.5. McKesson Corporation 13.5.1. Overview 13.5.2. Financial Overview 13.5.3. Product Offerings 13.5.4. Developments 13.5.5. Business Strategy 13.6. IBM 13.6.1. Overview 13.6.2. Financial Overview 13.6.3. Product Offerings 13.6.4. Developments 13.6.5. Business Strategy 13.7. Medecision 13.7.1. Overview 13.7.2. Financial Overview 13.7.3. Product Offerings 13.7.4. Developments 13.7.5. Business Strategy 13.8. GetWellNetwork, Inc. 13.8.1. Overview 13.8.2. Financial Overview 13.8.3. Product Offerings 13.8.4. Developments 13.8.5. Business Strategy 13.9. MEDHOST 13.9.1. Overview 13.9.2. Financial Overview 13.9.3. Product Offerings 13.9.4. Developments 13.9.5. Business Strategy 13.10. Lincor 13.10.1. Overview 13.10.2. Financial Overview 13.10.3. Product Offerings 13.10.4. Developments 13.10.5. Business Strategy 14. Analyst Opinion 15. Annexure 15.1. Report Scope 15.2. Market Definitions 15.3. Research Methodology 15.3.1. Data Collation and In-house Estimation 15.3.2. Market Triangulation 15.3.3. Forecasting 15.4. Report Assumptions 15.5. Declarations 15.6. Stakeholders 15.7. Abbreviations
Tables TABLE 1. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 2. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HARDWARE, BY GEOGRAPHY , 2021-2030 (USD BILLION) TABLE 3. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 4. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR STANDALONE SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 5. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTEGRATED SOFTWARE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 6. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SERVICES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 7. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 8. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PREMISE MODE, 2021-2030 (USD BILLION) TABLE 9. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CLOUD-BASED MODE, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HEALTH MANAGEMENT, 2021-2030 (USD BILLION) TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR HOME HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR SOCIAL, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 14. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FINANCIAL HEALTH MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY THERAPEUTIC AREA, 2021-2030 (USD BILLION) TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, 2021-2030 (USD BILLION) TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CARDIOVASCULAR DISEASES (CVD), BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DIABETES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 19. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OBESITY, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 20. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR CHRONIC DISEASES, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 21. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR WOMEN'S HEALTH, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 22. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR FITNESS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 23. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY FUNCTIONALITY, 2021-2030 (USD BILLION) TABLE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR INTRODUCTION, 2021-2030 (USD BILLION) TABLE 25. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR E-PRESCRIBING, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 26. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR VIRTUAL CONSULTATION, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 27. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENT/CLIENT SCHEDULING, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR DOCUMENT MANAGEMENT, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 29. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 30. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PROVIDERS, 2021-2030 (USD BILLION) TABLE 31. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PAYERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 32. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR PATIENTS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 33. PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE FOR OTHER END USERS, BY GEOGRAPHY, 2021-2030 (USD BILLION) TABLE 34. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 35. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 36. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 37. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 38. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 39. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 40. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 41. U.S PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 42. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 43. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 44. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 45. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 46. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 47. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 48. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 49. MEXICO PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 50. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 51. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 52. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 53. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, END USE INDUSTRIES, 2021-2030 (USD BILLION) TABLE 54. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 55. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 56. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 57. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 58. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 59. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 60. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 61. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 62. U.K PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 63. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 64. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 65. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 66. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 67. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 68. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 69. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 70. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 71. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 72. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 73. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 74. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 75. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 76. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 77. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 78. ROE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 79. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COUNTRY, 2021-2030 (USD BILLION) TABLE 80. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 81. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 82. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 83. ASIA PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 84. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 85. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 86. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 87. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 88. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 89. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 90. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 91. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 92. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 93. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 94. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 95. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 96. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 97. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 98. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 99. REST OF APAC PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 100. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 101. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 102. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 103. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 104. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 105. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 106. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 107. BRAZIL PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 108. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 109. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 110. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 111. ARGENTINA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 112. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 113. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 114. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 115. MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 116. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 117. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 118. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 119. SAUDI ARABIA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 120. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 121. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 122. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 123. UAE PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 124. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY COMPONENT, 2021-2030 (USD BILLION) TABLE 125. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY DELIVERY MODE, 2021-2030 (USD BILLION) TABLE 126. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY APPLICATION, 2021-2030 (USD BILLION) TABLE 127. REST OF MIDDLE EAST AND AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET VALUE, BY END USER, 2021-2030 (USD BILLION) TABLE 128. ALLSCRIPTS HEALTHCARE, LLC: FINANCIALS TABLE 129. ALLSCRIPTS HEALTHCARE, LLC: PRODUCTS & SERVICES TABLE 130. ALLSCRIPTS HEALTHCARE, LLC: RECENT DEVELOPMENTS TABLE 131. ORION HEALTH: FINANCIALS TABLE 132. ORION HEALTH: PRODUCTS & SERVICES TABLE 133. ORION HEALTH: RECENT DEVELOPMENTS TABLE 134. CERNER CORPORATION: FINANCIALS TABLE 135. CERNER CORPORATION : PRODUCTS & SERVICES TABLE 136. CERNER CORPORATION: RECENT DEVELOPMENTS TABLE 137. MCKESSON CORPORATION: FINANCIALS TABLE 138. MCKESSON CORPORATION: PRODUCTS & SERVICES TABLE 139. MCKESSON CORPORATION: RECENT DEVELOPMENTS TABLE 140. ATHENAHEALTH, INC.: FINANCIALS TABLE 141. ATHENAHEALTH, INC.: PRODUCTS & SERVICES TABLE 142. ATHENAHEALTH, INC.: RECENT DEVELOPMENTS TABLE 143. IBM: FINANCIALS TABLE 144. IBM: PRODUCTS & SERVICES TABLE 145. IBM: RECENT DEVELOPMENTS TABLE 146. MEDECISION: FINANCIALS TABLE 147. MEDECISION: PRODUCTS & SERVICES TABLE 148. MEDECISION: DEVELOPMENTS TABLE 149. GETWELLNETWORK, INC.: FINANCIALS TABLE 150. GETWELLNETWORK, INC.: PRODUCTS & SERVICES TABLE 151. GETWELLNETWORK, INC.: RECENT DEVELOPMENTS TABLE 152. MEDHOST: FINANCIALS TABLE 153. MEDHOST: RODUCTS & SERVICES TABLE 154. MEDHOST: RECENT DEVELOPMENTS TABLE 155. LINCOR: FINANCIALS TABLE 156. LINCOR: PRODUCTS & SERVICES TABLE 157. LINCOR: RECENT DEVELOPMENTS
Publisher: IHR Insights
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support